Bound by Attention: Bringing rats and humans togetherNovember 19, 2008When picking through a basket of fruit, it doesn't seem very difficult to recognize a green pear from a green apple. This is easy, thanks to "feature binding"- a process by which our brain combines all of the specific features of an object and gives us a complete and unified picture of it. For example, upon first seeing the fruit basket, our brain immediately gets to work, connecting (or binding) information about each fruit's shape to its color to ensure that we select the green apple we are craving instead of a green pear. However, if our brain gets distracted, our ability for feature binding is reduced and we may inadvertently end up biting into the green pear instead. It was well known which areas of the brain are involved in feature binding, but it was unclear which neurotransmitters (or brain chemicals) contribute to this important process. Psychologists Leigh C.P. Botly and Eve De Rosa from the University of Toronto wanted to investigate if acetylcholine is involved in feature binding. Acetylcholine is a neurotransmitter that is important for attention and seemed like a good candidate for playing a role in feature binding as well. A group of volunteers participated in a feature binding task (choosing among various shapes and colors), with some of them being distracted throughout the duration of the task. The psychologists also developed a feature binding task for rats (having them choose among variously scented food bowls) and treated some of the animals with the drug scopolamine, which temporarily blocks the effects of acetylcholine. The results, reported in the November issue of Psychological Science, a journal of the Association for Psychological Science, showed that patterns of behavior were very similar in distracted humans and rats on scopolamine. Both the drug treated rats and distracted humans had a decreased ability to complete the feature binding task (which required the ability to combine many different features of an object together) although their ability to process just single features of an object (e.g. one specific color or odor) was not affected. In other words, blocking the rats' cholinergic system (by using scopolamine) made them behave similarly to distracted humans, suggesting that the neurotransmitter acetylcholine is necessary for feature binding to occur. The authors note that "acetylcholine may provide the attentional 'glue' for feature binding." Their findings have important clinical implications, as the development of a better animal model of distraction and inattention may lead to improved therapies and treatments for a variety of disorders, such as Alzheimer's disease. Association for Psychological Science |
|||||||||||||||||||||
| Related Acetylcholine Current Events and Acetylcholine News Articles New Down syndrome treatment suggested by Stanford/Packard study in mice At birth, children with Down syndrome aren't developmentally delayed. But as they age, these kids fall behind. Memory deficits inherent in Down syndrome hinder learning, making it hard for the brain to collect experiences needed for normal cognitive development. Developmental delay could stem from nicotinic receptor deletion The loss of a gene through deletion of genetic material on chromosome 15 is associated with significant abnormalities in learning and behavior, said a consortium of researchers led by Baylor College of Medicine (www.bcm.edu) in a report that appears online today in the journal Nature Genetics. Risk of abnormally slow heart rate twice as high in those taking drugs to slow Alzheimer's People taking one of several drugs commonly prescribed to treat Alzheimer's disease are more likely to be hospitalized for a potentially serious condition called bradycardia than patients not taking these medications. Promising new treatment for Alzheimer's suggested based on Hebrew University research Research carried out at the Hebrew University of Jerusalem has resulted in a promising approach to help treat Alzheimer's disease in a significant proportion of the population that suffers from a particularly rapid development of this disease. Barrow researchers identify new brain receptor, possible target for Alzheimer's treatment Barrow Neurological Institute researchers have identified a novel receptor in the brain that is extremely sensitive to beta-amyloid peptide (AB) and may play a key role in early stages of Alzheimer's disease. Defeating nicotine's double role in lung cancer A lung cancer treatment that inhibits nicotine receptors was shown to double survival time in mice, according to Italian researchers. Genes: An extra hurdle to quitting smoking during pregnancy? Researchers from the Peninsula Medical School and the University of Bristol, using data from the Avon Longitudinal Study of Parents and Children and the Exeter Family Study of Childhood Health, have identified a common genetic variant that explains why some women may find it more difficult to quit smoking during pregnancy. Nicotine may have more profound impact than previously thought Nicotine isn't just addictive. It may also interfere with dozens of cellular interactions in the body, new Brown University research suggests. Caltech researchers find tiny genetic change keeps nicotine from binding to muscle cells A tiny genetic mutation is the key to understanding why nicotine--which binds to brain receptors with such addictive potency--is virtually powerless in muscle cells that are studded with the same type of receptor. Nose-spray vaccine against botulism effective in first tests A preclinical study found a new nasal spray vaccine to provide complete protection against a major botulism toxin, according to a study published today in the Nature journal Gene Therapy. More Acetylcholine Current Events and Acetylcholine News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||